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Matt B. Thomas and Andrew F. Read 
Matt Thomas – is a population ecologist specialising in biological pest control. His group has 
experience studying a range of biocontrol problems in temperate and tropical settings including 
several years working as part of a research programme to develop a biopesticide for control of 
locusts and grasshoppers in Africa. He is currently co-chair of an international consortium 
researching novel use of fungi for control of mosquitoes and malaria in Africa.  
Andrew Read – is an evolutionary ecologist specialising in host-parasite interactions.  He is 
particularly interested in the evolution of pathogen traits of medical and veterinary importance, 
including infectiousness, virulence, drug resistance and vaccine escape.  Most of his work has 
involved malaria, but his group has also worked on viruses, bacteria, trypanosomes and 
nematodes.   A major theme is trying to understand how public and animal health interventions 
shape pathogen evolution, and how to avoid evolutionary mismanagement of infectious disease. 
 
Abstract  Recent research has raised the prospect of using insect fungal pathogens for 
the control of vector-borne diseases such as malaria.  In the past, microbial control of 
insect pests in both medical and agricultural sectors has generally had limited success. 
We propose that it may now be possible to produce a cheap, safe and green tool for the 
control of malaria which, in contrast to most chemical insecticides, will not eventually be 
rendered useless by resistance evolution. Realising this potential will require lateral 
thinking by biologists, technologists and development agencies. 
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A key component of integrated control of vector-borne diseases such as malaria and 
dengue is the use of insecticides that target the insect vectors. However, the utility of 
insecticides is being undermined by problems of insecticide resistance, environmental 
contamination and risks to human health1-3. Therefore alternative approaches are 
required2. Biocontrol using biopesticides that are based on naturally occurring microbial 
pathogens is one such method.   
Insects can be infected by bacterial, viral, protozoan and fungal pathogens. Of 
these, fungal entomopathogens are perhaps the best-suited for development as 
biopesticides because they do not require ingestion by the host.  Instead, fungi infect by 
external contact with the host (see FIG 1). The time taken to kill the host following 
infection varies from 2-5 days to days or weeks, depending on the particular host-
pathogen combination and environmental conditions4.  
Few biopesticide products have been widely used, in spite of their potential. 
Indeed, on a global scale, penetration of biocontrol technology into the pesticide market 
has been minimal; less than 2% of global pest control sales (US$30b annually) comprise 
biocontrol and >70% of this small proportion are biopesticide products that are based on 
the crystal toxin-forming bacterium Bacillus thuringiensis5,6.  
This failure to adopt biocontrol strategies raises a fundamental question: is the 
success of microbial biocontrol limited by inadequate technology, unfavourable 
economics or a complex interplay of several factors? In this article we draw on recent 
advances in the development of biopesticides based on entomopathogenic fungi to 
explore this question. We use insights from the recent successful development of 
biopesticides for the control of locusts and grasshoppers to examine the potential for 
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development of a biopesticide to infect mosquitoes in resting and breeding sites in 
residential settings.  
 
Biopesticides for locusts and grasshoppers  
In 1989, in response to concerns over the environmental and human health 
consequences of extensive chemical applications against locusts and grasshoppers in 
Africa, the international donor community supported the initiation of a collaborative 
research programme to develop a more sustainable, biological pesticide for locust and 
grasshopper control. The programme, named LUBILOSA (Lutte Biologique contre les 
Locustes et les Sauteriaux), was founded on preliminary research that had identified a 
virulent strain of the entomopathogenic fungus, Metarhizium anisopliae var. acridum, 
and had revealed how formulation of fungal spores in oil could enable infection in the 
very low relative humidity conditions7,8,9 (see FIG 2).  The end product was Green 
Muscle®, which has now been registered in several countries including South Africa, 
Zambia, Namibia, Sudan, Mozambique and much of French West Africa. Since 
LUBILOSA finished in 2001, several projects have continued to evaluate the impact of 
Green Muscle® on locust and grasshopper species in Africa and Europe, to optimize its 
usage9.  
In 1993, the Commonwealth Scientific and Industrial Research Organisation 
(CSIRO) collaborated with LUBILOSA to develop a biopesticide (based on an Australian 
strain of the same subspecies used in Africa) for use against locusts and grasshoppers in 
Australia10,11. This resulted in Green Guard®, which was registered in 200511. Green 
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Guard® now forms an integral part of locust control operations in Australia, with a 
steadily increasing market share as the technology becomes established11,12.  
The production of Green Muscle® and Green Guard® show that effective 
biopesticide products based on entomopathogenic fungi can be developed. LUBILOSA 
cost ~US$17 million, which compares well with the estimated US$70-100 million that is 
required to develop a new synthetic pesticide compound9. Although there are some 
cheaper products available, Green Muscle® and Green Guard® are price competitive 
with most established insecticides. Importantly, of all the products for locust and 
grasshopper control, they have the lowest environmental impact and can be used near 
water courses, organic crops and conservations areas, satisfying the demand for more 
environmentally sustainable technologies. 
More generally, the locust biopesticide programmes have advanced our 
knowledge in a range of areas such as isolate screening, formulation, mass production, 
quality control, storage, application, environmental impact, safety testing and host-
pathogen ecology. These technical advances have been accompanied by developments in 
capacity in areas such as commercial production and distribution, product registration and 
extension to end-users. Overall, such developments provide a solid foundation for the 
development of fungus-based biopesticides for use in integrated strategies for control of 
diseases such as malaria (and also dengue and filariasis).  
 
Proof of concept for malaria control 
Several studies have investigated the use of microbial biocontrol to kill mosquitoes (for a 
review, see REFS 13-15). Typically, virulent pathogens have been isolated, with the aim 
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of developing biopesticides to kill mosquito larvae13,14,16. More recently several studies 
have highlighted the potential use of fungal pathogens to kill adult mosquitoes17-20. The 
common approach behind these studies is to infect insects by exposure to oil-formulated 
fungal spores that have been applied to surfaces on which adult mosquitoes rest after 
blood meals. 
 Initial laboratory-based bioassays revealed that mosquitoes were readily infected 
by exposure to entomopathogenic fungi  and that some fungal isolates caused 100% 
mortality of adult Anopheles and Culex spp. in 7-14 days, depending on dose, formulation 
and fungal strain17-19. Further studies used a rodent malaria model to examine the effect 
of fungal infection on malaria transmission potential19 (see FIG 3). The results indicated 
an 80-fold reduction in the number of mosquitoes able to transmit malaria following 
exposure of the insects to the fungal pathogen. This reduction resulted from two 
complementary effects of fungal infection. First, fungal infection caused high levels of 
mosquito mortality by day 14 after blood feeding (when sporozoites are present in the 
mosquito mouthparts). Moreover, the daily mortality rate of mosquitoes infected with 
both fungus and malaria increased compared with insects infected with just the fungus 
from day 11. Second, significantly fewer surviving mosquitoes had sporozoites in their 
mouthparts compared with control mosquitoes infected with malaria alone, indicating a 
negative effect of fungal infection on survivorship/development of the malaria parasite 
inside the mosquito. In addition, fungus-infected mosquitoes were less likely to blood-
feed (FIG 3), further reducing transmission potential19,21. Finally, a small-scale study in 
village houses in Tanzania confirmed the feasibility of infecting mosquitoes with virulent 
fungi under field conditions in Africa20. This investigation used a relatively low dose of 
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an experimental formulation applied over a small surface area, but still showed that 34% 
of mosquitoes collected from targeted village houses were infected with fungi. Simple 
epidemiological models predict that even this relatively low level of infection would 
result in a 75% reduction in Entomological Inoculation Rate (EIR) at this field site20. The 
study used fungus-treated black cloths that were pinned to the ceilings of dwellings. 
These cloths could be repeatedly treated with spores at relatively little cost or 
inconvenience.  
 These studies highlight the potential of fungal biopesticides to substantially 
reduce mosquito vectorial capacity using currently available technology. However, the 
literature is littered with examples of promising microbial agents and candidate 
biopesticide technologies yet, as evidenced by the very limited penetration of the 
chemical pesticide market, very few realize this potential. So we consider next some of 
the features that represent both the strengths and weaknesses of the fungal biopesticide 
approach. We draw on lessons from the locust biopesticide research and consider specific 
aspects relating to biopesticide control of malaria. As such we do not consider more 
generic, albeit important, R&D issues such as optimization of production, delivery 
systems, field testing, or safety issues (for a discussion of the latter see REFS 22-24).  
 
Disease pathology and biopesticides 
A crucial factor for the successful transmission of malaria is the longevity of the 
mosquito compared with the approximately two week parasite incubation period25,26. 
Even small reductions in adult mosquito longevity after an infective blood meal can have 
a large impact on malaria dynamics. Thus, unlike most other insect control problems it is 
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not necessary to rapidly kill the mosquito with a virulent pathogen. Moreover, emphasis 
on the ‘pesticidal’ properties of entomopathogens overlooks their potential to influence 
insect behaviour and fitness in subtle ways that may negatively impact malaria 
transmission, without necessarily reducing vector density. For example, numerous insect-
pathogen studies indicate the potential for sub- or pre-lethal pathogen effects. Locusts 
infected with entomopathogenic fungi have altered feeding behaviour, fat body 
accumulation, development rate, fecundity, mobility and predator escape responses 
before death27-31. Similarly, preliminary research indicates that infected mosquitoes may 
have a reduced propensity to feed prior to death19,21 and  there is evidence that fungal 
pathogens can affect not only the mosquito, but also the survivorship of malaria within 
the mosquito19. The mechanisms that underlie this anti-malaria effect are unknown but 
might include alterations in host nutritional balance leading to resource competition, up-
regulation of immune responses, or production of secondary metabolites in the 
haemolymph.  
 The deleterious effects of sub-lethal pathogens on the capacity of insects to 
function as vectors of disease has been virtually ignored although sub-lethal effects are 
the most common outcome of infection. Exploiting sub-lethal effects of pathogens could 
present new opportunities for development of biopesticides.   
 
Evolution of resistance 
Anopheles mosquitoes have proved adept at evolving resistance to chemical 
insecticides32-34. Indeed, resistance to insecticides has appeared in the major insect 
vectors from every genus, with examples of resistance to every chemical class of 
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insecticide35. Biopesticide control would be similarly unsustainable if the widespread use 
of fungal entomopathogens provided a selective pressure that resulted in evolution of 
fungal resistance mechanisms in mosquitoes22,36.   
Little is known about genetic variation in fungal susceptibility among Anopheles 
populations.  All mosquitoes may be fully susceptible (we can find no records of 
complete resistance against fungal pathogens in any insect).  However, there is evidence 
for genetic variation in susceptibility (time to death) to entomopathogenic fungi in 
aphids37,38 and Drosophila39, as well as environmentally40 and behaviourally-mediated 
host responses that alter effective resistance4,41,42.  Moreover in the long history of 
malaria control, resistance to all interventions has eventually evolved, even in the absence 
of pre-existing resistance.  If biopesticides are to avoid the depressing fate of so many 
other malaria control measures, we need to maximise the reduction in malaria 
transmission without imposing strong selection on vector populations.   There are several 
reasons for thinking that this might be achievable with a fungal biopesticide. 
First, the negative effects of pathogenic fungi on the mosquito host occur 
relatively late in the lifecycle of the mosquito.  Fungal-induced mosquito mortality and 
reduced propensity to blood feed occur after most mosquitoes in natural populations have 
already died (FIG 4). It is well known in the context of the evolution of ageing that 
beneficial mutations acting late in life are subject to weak selection because they confer 
fitness benefits after the majority of individuals have anyway ceased reproducing43,44.  
Thus, even if Anopheles could develop resistance to fungi, biopesticides might impose 
only weak selection for that resistance. Such reductions in selection pressure could 
translate into decades more of effective use of a product.  Moreover, there may actually 
Thomas, M.B & Read, A.F. 2007. Can fungal biopesticides control malaria? Nature Microbiology Reviews 
5: 377-383. 
 9 
be no selection for resistance. If the possession of fungal resistance mechanisms entails 
metabolic costs, all individuals in a population would pay the price for a benefit 
experienced only by a few.  Indeed, while it might be tempting to deploy more virulent 
isolates that either kill insects more quickly, or kill insects at a constant daily rate, this 
capacity for killing would need to be balanced against potentially sharp increases in 
selection pressure to evolve resistance.  
This argument is subject to a couple of corollaries. Slow speed of kill potentially 
increases the level of biopesticide coverage necessary to impact on malaria transmission 
because the slower the speed of kill, the greater the need for the mosquito to become 
infected at the first or second blood feed. This will require that a high proportion of 
houses are treated and that there is a high probability of infection per feed.   It might also 
be that fungal pathogens could place an evolutionary pressure on the malaria parasite to 
produce sporozoites before the fungus kills the host36. However, given that natural 
mosquito survival is so low, there must already be strong selection for more rapid 
development.  There must, therefore, be very substantial fitness costs associated with 
shorter incubation periods.  Even if fungal biopesticides did tip the balance in favour of 
more rapid development, it is difficult to assess the overall effect on human disease 
burdens of any such evolution without knowing what these fitness costs are. 
A second reason for thinking that fungal biopesticides would not be undermined 
by mosquito resistance is the possibility that fungal infection has a direct anti-malarial 
effect, reducing the prevalence of sporozoites. It would be highly desirable to isolate 
fungal strains that had an increased propensity to reduce mosquito infectiousness, since 
this effect of the pathogen does not result in selection for fungal resistance in mosquitoes. 
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Indeed, some fungal isolates can reduce sporozoite prevalence without causing any 
mosquito mortality (Blanford, Read and Thomas unpubl data); this effect could in 
principle be enhanced by paratransgenesis (Box).  Similar to above, however, products 
relying only on these anti-malarial effects might in the long run suffer from the evolution 
of resistant malaria parasites.  
A third reason for thinking that biopesticides could be evolution-proof is that, 
mosquitoes infected with malaria parasites are more likely to die following fungal 
infection than mosquitoes that are not infected with the parasite (FIG 3).  Malaria-
infected mosquitoes normally comprise less than 10% of the insect population. If the 
main effect of a fungal isolate was to reduce the fitness of malaria-infected mosquitoes 
(rather than any mosquito), this should reduce selection pressure for fungal resistance 
across the mosquito population overall, and may even select for increased malaria 
refractoriness45. Again, this would reduce malaria transmission without imposing a 
selection for fungal resistance.   
Even if anti-fungal resistance is unlikely to emerge in response to biopesticide 
use, it would still be extremely interesting to understand mechanisms of fungal resistance 
in mosquitoes. For instance, are any resistance mechanisms isolate- or strain-specific?  If 
they are, combinations of strains could be used in single biopesticide formulations to 
minimise further the risk for resistance evolution. In any case, because of the very 
different nature of fungal infection and the resultant insect immune response, it seems 
extremely unlikely that anti-fungal resistance would be related to ‘metabolic’ or 
‘knockdown’ insecticide resistance mechanisms, so it should be possible to use 
biopesticides in localities in which evolution has rendered chemical insecticides obsolete.  




Formulation and application 
Application of spores inside houses, where many malaria vector species prefer to blood-
feed and rest, optimises the likelihood of fungus contact and infection. However, 
persistence of the fungal pathogens on treated surfaces has been identified as a key factor 
that will determine ultimate viability of the biopesticide approach46.  
 The active ingredient of a biopesticide is a living organism and so there will be 
biological limits to persistence. We must not expect that a biopesticide can, or necessarily 
should, have persistence characteristics similar to, for example, the long lasting 
insecticide treated nets, which can remain effective for several years47.  
 Preliminary studies indicate that viable spores can be recovered from treated 
surfaces after 3 months but that the percentage infection of mosquitoes exposed to these 
surfaces at this time is very low (Blanford, Read and Thomas unpubl. data). However, 
studies on of the use of fungal pathogens to control Tsetse fly (Glossina fuscipes) in 
Kenya indicated that spores retained their viability for 31 days in the field, and efficacy 
against G. fuscipes was not affected48. Moreover studies on spore storage indicate that 
fungal spores can remain viable for more than 12 months depending on prevailing 
temperature and humidity49,50. Thus, there is scope for achieving long-term infectivity but 
there is little understanding of the variation in infective half life between different fungal 
strains and how much persistence is determined by biological variation, versus factors 
such as dose and formulation under different environmental conditions. A fungal isolate 
that is only moderately pathogenic but that persists and remains infectious, could 
ultimately be more useful as a biopesticide than an isolate that is very virulent but 
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requires reapplication every two weeks. Similarly, an isolate that is easy to mass produce 
could prove more effective (both in terms of economics and impact) than an isolate that is 
more virulent but difficult to produce in operational quantities. The amenability of 
candidate microbial agents for commercial development has been identified as a critical 
factor in determining biopesticide success but is rarely considered as a criterion in isolate 
selection51. 
 One area where there is substantial scope for maximising infectivity and 
persistence is through formulation. There is generally little specialist research on 
formulation of microbial agents52. However, the agrochemical, pharmaceutical and food 
processing industries have considerable expertise in producing formulations that enhance 
shelf life, protect products from decay and UV radiation and enable targeted or slow 
release of an active ingredient. The novel application of these established technologies 
could revolutionise biopesticide use52.  
 
Technology transfer and implementation  
In Australia, Green Guard® was used to treat >60,000ha of locust infestations 
during the 2005-6 season12. Adoption of Green Muscle® in Africa, on the other hand, has 
been much more patchy.  There are several factors contributing to the contrasting 
situations on the two continents, including differences in socio-economics, capacity, 
socio-political complexities and government and donor commitment9,53. The important 
insight, however, is that successful implementation and adoption require more than just 
technological innovation.  
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Studies on the demand for malaria control interventions indicate correlations 
between willingness to pay and socio-economic status54 and potentially very low 
threshold costs for deriving net benefit from control technologies55. Based on the current 
costs of products such as Green Muscle® and Green Guard®, and the experimental dose 
rates used in initial evaluation of fungi for control of malaria19, we estimate it would cost 
approximately US$ 0.01 for enough biopesticide product to treat 1m2. This is an 
encouraging figure, although it does not include labour costs, or the cost of cloth or 
netting for impregnation etc. and so cost will still be a major factor, including the 
question of who pays for the biopesticide. Both locust control biopesticides ultimately 
followed a public-private partnership model engaging small-to-medium-scale commercial 
companies to produce and distribute the products at national or regional levels. However, 
although requiring good quality control56,57 the methodologies for mass production are 
inherently ‘low-tech’ (see FIG 2). Local- (or even village-) scale production of 
biopesticides might be feasible, which would contribute towards ownership and 
acceptance of the technology at the community level. Such ‘bottom-up’ approaches are 
impossible with chemical insecticides but evidence suggests that control programmes are 
most successful when there is good cooperation owing to education, training and 
community involvement in implementation58.  This need for cooperation identifies an 
important role for participatory approaches with end-users engaged early in the 
development process; something which is now recognised in the WHO policy for 
integrated vector management59.  
Moreover, it is also important to match use (and user expectation) with product 
specification. Areas differ substantially in the seasonal incidence of malaria and their 
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epidemic versus endemic status. In some settings, 2 or 3 treatments of even a short-
persistence product could provide affordable, year-round control. Other settings might 
require repeated monthly applications which could prove prohibitive, depending on 
capacity and socio-economic context. An alternative a strategic approach could be to use 
a biopesticide over restricted temporal or spatial scales to disrupt cycles of resistance 
evolution and increase the durability of existing chemical interventions. This would 
represent a highly innovative application of biocontrol and could dramatically alter the 
benefit:cost ratio of the technology.  
 
Concluding remarks 
The successful development of biopesticide products for locust control demonstrates the 
potential for translation of research through to practice. Although this took several years, 
technical and regulatory developments should enable new applications, such as mosquito 
control, to advance to the market more rapidly. The specific features of fungal infection 
such as late acting mortality, transmission blocking and host behavioural changes, 
provide opportunities to minimise the risk of resistance evolution. Indeed with fungal 
biopesticides, we are in a perhaps unique position in malaria control history: we can think 
about preventing evolutionary outcomes now, rather than after a once promising method 
has begun to fail. There is also scope for innovative applications of established 
knowledge from other industries. Nonetheless, numerous research challenges remain and 
we need to recognise there will be technical and biological constraints that set limits to 
the approach. Moreover, contrasting experiences with the locust biopesticides in Africa 
and Australia reveal the need to support not only research and development but also, 
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implementation and capacity building; to make such technologies a reality we cannot 
simply rely on the initial technical innovation and market pull. This is an important 
interdisciplinary interpretation that sets a challenge to researchers working to develop 
alternative pest control technologies and the donors and agencies that support this.  
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Appresorium Is a flattened, hyphal "pressing" organ produced by a germinating fungal 
spore, from which an infection peg grows and penetrates the host cuticle 
Biocontrol or Biological Control is the use of living natural enemies such as predators, 
parasitoids or pathogens, to control pest insects, weeds, or diseases. 
Biopesticide In simplest terms refers to a pesticide that is biological in origin (i.e., 
viruses, bacteria, fungi, pheromones, natural plant compounds). The approach is 
characterised by inundative applications of a living organism, with little or no reliance on 
the organism to reproduce or be self-sustaining in order to bring about control.  In this 
regard, the biological control agent is being used as a chemical pesticide analogue. 
Entomological Inoculation Rate (EIR) A measure of the frequency with which a human 
is bitten by an infectious mosquito. 
Haemocoel The body cavity of an arthropod in which most of the major organs are 
found. It is filled with the arthropod equivalent of blood, called haemolymph.  
Oocyst A walled, vegetatively replicating malarial parasite under the basal lamina of the 
mosquito midgut in which the transmissible sporozoites form.  
Parasite incubation period The time from infection of the mosquito following a blood 
feed from a human host carrying malaria, to the point at which the mosquito is 
infectiousness and can transmit the parasite to a new host during a further feeding bout. 
Throughout large areas of malaria transmission the parasite incubation period is 12-14 
days. 
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Paratransgenic approaches (or Paratransgenesis) Genetic manipulation of organisms 
associated with a vector (usually commensal or symbiotic bacteria but in our case, fungal 
entomopathogens) to alter the vector’s ability to transmit a pathogen.  The vector itself is 
not genetically modified. 
Sporozoite Small elongated cells resulting from repeated division of the oocyst. In the 
case of the malarial parasite, it is the sporozoites that concentrate in the salivary glands 
and are introduced into the blood by the bite of a mosquito.  
Vectorial capacity Provides a measure of disease risk as determined by the ability of a 
vector to successfully transmit disease and incorporates aspects of vector competence, 
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Box 1 Paratransgenic Approaches 
Whilst there is a wealth of lethal and sub-lethal properties of natural fungal isolates or 
isolate combinations to be explored, there would seem considerable additional promise 
for utilising residual sprays of fungal pathogens in novel paratransgenic approaches. 
Regulatory and ethical concerns notwithstanding, because fungal pathogens function by 
contact with the insect host they could constitute a novel delivery mechanism for anti-
malarial or anti-mosquito biomolecules. Genetic modification could enable fungal 
pathogens to express toxins or, for example, effector molecules that block sporogony 
within the vector60. Lack of a practical delivery mechanism has been identified as a 
significant constraint for malaria control interventions involving effector molecules such 
as RNAi61. The potential to transform fungal entomopathogens is well established. 
Metarhizium anisopliae, for example, has already been engineered to over-express a toxic 
protease to increase the speed with which is kills Lepidopteran pests in agricultural 
systems62.  Secondary transfer of fungi from mosquitoes is very unlikely to occur (fungal 
spores are only produced once the insect is dead, and many cadavers are scavenged 
before sporulating, limiting potential for transfer to other hosts) so that fungal transgenes 
would be easier to control than mosquito transgenes.  Moreover, whereas encouraging the 
spread of transgenes in mosquito populations is fraught with ecological and population 
genetic problems63,64, the fitness of the transgenes (essentially the ability of a modified 
gene to persist and spread through a population) would be relatively unimportant in a 
biopesticide where repeated application is envisaged and natural reproduction and 
transmission are of little consequence.  
 





Figure 1. Fungal entomopathogens act via external contact with the insect host. The 
in vivo development cycle of entomopathogenic fungi, such as Beauveria bassiana and 
Metarhizium anisopliae, involves sequential steps of adhesion of conidia (spores) to the 
host cuticle, germination of the conidia and production of germ tube and appresorium 
(penetration structure), penetration of the cuticle via a combination of mechanical 
pressure and the action of cuticle degrading enzymes, vegetative growth within the host 
haemoceol and then production of externally-borne conidia upon death of the host65,66. 
The host cuticle provides the first line of defence against infection and plays a key role in 
determining specificity of the fungus. If the fungus breaches the cuticle, successful 
infection depends on subsequent ability to overcome the insect innate immune response. 
Insects can respond in both a cellular and humoral manner to fungal infection, with 
immune activation occurring as early as the point of cuticle degradation during the 
penetration process65. Fungi generally have two strategies for overcoming the host 
defence responses; development of cryptic growth forms that are effectively masked from 
Thomas, M.B & Read, A.F. 2007. Can fungal biopesticides control malaria? Nature Microbiology Reviews 
5: 377-383. 
 27 
the insect defence responses and/or production of immuno-modulating substances which 












Figure 2. Use of biopesticides for sustainable control of locusts and grasshoppers in 
Africa. A virulent strain of the fungal entomopathogen Metarhizium anisopliae var 
acridum was isolated from an infected cadaver collected from the field (top picture shows 
a dead, infected desert locust with spores being produced at the inter-segmental 
membranes). Relatively simple techniques were then developed for in vitro mass 
production. Shown here is a small-scale production facility in west Africa where spores 
are grown in bowls using part-cooked rice as a solid substrate. Fungal spores are then 
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harvested from the rice and formulated in oil for ultra low volume application using 
hand-held, vehicle or aerial-mounted (not shown) sprayers. Infected locusts and 
grasshoppers typically die in 7-25 days (speed of kill is strongly influenced by 
environmental temperature and insect thermal behaviour in this system4) and under 
























Figure 3. Fungal infection substantially reduces the proportion of mosquitoes 
potentially able to transmit malaria. In the fungal biopesticide approach female 
mosquitoes contact fungal spores from treated surfaces as they rest to digest a blood 
meal. As the fungal infection progresses mosquitoes die and in the right conditions 
eventually sporulate, producing a mat of fungal spores on the outside of the cadaver (top 
right). a Infection with the entomopathogenic fungus Beauveria bassiana dramatically 
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reduces survival of Anopheles stephensi mosquitoes by day 14 (the time following an 
infectious blood feed at which an individual mosquito becomes able to transmit malaria). 
b In addition there appears an interaction with malaria (Plasmodium chabaudi) whereby 
daily mortality rates accelerate from day 11 in those mosquitoes carrying both fungus and 
malaria. c Furthermore, mosquitoes infected with the fungus exhibit a significant decline 
in propensity to blood feed as the disease progresses. Finally, survivorship or 
development of the malaria parasite inside the mosquito is affected such that even if 
mosquitoes survive, there is less chance of having the infectious stage of the malaria 
parasite (the sporozoites) in their mouthparts (figure shows mean (± SEM) proportion of 
the starting population of mosquitoes in the Malaria and Malaria+Beauveria treatments 
positive for malaria oocysts at day 7 and sporozoites at day 14 after infectious blood 
meal).  The effect is an 80-fold reduction in potential of mosquitoes to transmit malaria 















Figure 4. The sustainability of chemical and biological interventions against adult 
mosquitoes. a In their normal life cycle female mosquitoes take a blood meal every 2-4 
days and use this to mature sequential batches of eggs (x-axis). Natural mortality is 
generally high (survivors, y-axis) such that the majority of the reproductive output 
(vertical arrows) from a population accrues over the first 1-3 feeding/oogenic cycles. 
Relatively few mosquitoes actually survive long enough (12-14 days) in the field for the 
malaria parasite to complete its development, migrate to the mosquito mouthparts and get 
transmitted to a new human host (‘infectious’). b Exposure to a fast acting insecticide 
following the first blood meal reduces survivorship and prevents malaria transmission. 
However, the rapid mortality carries a big fitness cost and creates a substantial selection 
pressure for development of resistance. c Relative slow speed of fungal kill helps mitigate 
selection pressure as infected mosquitoes can still complete the important early oogenic 
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cycles. An isolate that allows a high level of survival (and hence egg production) over the 
first 7-9 days, for instance, but then causes extensive mortality will still reduce malaria 
transmission but will impose little selection for resistance.  
 
 
